Rare Diseases Insights

Neil and Gaurav discuss the prevalence of rare diseases and the potential for specialized treatments. They delve into the financial aspects of developing therapies and the government's role in incentivizing companies to focus on rare diseases. The conversation highlights the importance of long-term investment in addressing rare medical conditions.